Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study

Blood. 2018 Jan 11;131(2):263-265. doi: 10.1182/blood-2017-06-790121. Epub 2017 Nov 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Erythroid Cells
  • Erythropoiesis
  • Humans
  • Pyrazoles
  • Thalassemia*
  • beta-Thalassemia*

Substances

  • INCB018424
  • Pyrazoles